![Andrew Yuen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Andrew Yuen
Analyst-Equity chez Gordonmd Global Investments LP
Profil
Mr. Andrew Yuen is a Senior Analyst at Gordonmd Global Investments LP.
Prior to joining, He was an Equity Research Associate for two years at The Capital Group.
Before joining The Capital Group, He was employed by J.P.
Morgan Securities LLC.
He holds a bachelor’s degree in Business Administration, with a concentration in Finance, from the University of Washington.
Postes actifs de Andrew Yuen
Sociétés | Poste | Début |
---|---|---|
Gordonmd Global Investments LP
![]() Gordonmd Global Investments LP Investment ManagersFinance Gordonmd Global Investments LP is a private company that combines medical and investing expertise to create a singular advantage for biopharmaceutical investors. The company is based in Beverly Hills, CA. The company is dedicated to sourcing highly differentiated investments through their experience and expertise as investment professionals with distinctive backgrounds in the medical/healthcare/finance space. The company was founded in 2021 by Craig Gordon, MD, a licensed physician, who has been the CEO since 2021. | Analyst-Equity | 01/01/2021 |
Formation de Andrew Yuen
University of Washington | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 1 |
---|---|
Gordonmd Global Investments LP
![]() Gordonmd Global Investments LP Investment ManagersFinance Gordonmd Global Investments LP is a private company that combines medical and investing expertise to create a singular advantage for biopharmaceutical investors. The company is based in Beverly Hills, CA. The company is dedicated to sourcing highly differentiated investments through their experience and expertise as investment professionals with distinctive backgrounds in the medical/healthcare/finance space. The company was founded in 2021 by Craig Gordon, MD, a licensed physician, who has been the CEO since 2021. | Finance |